The mechanism of this protective effect involved reduced CD4+ T cell proliferation and an increased regulatory population in the periphery following TRI MP administration, and these changes were also reflected in the paws during arthritis onset and associated with reduced recruitment/expansion of TNF-α producing myeloid cells. The gene discussed is CD4; the disease is arthritic joint disease.